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Available online 6 November 2015Trubanaman (TRUV) and Gan Gan (GGV) viruses are members of the tentatively assigned
Mapputta group of the genus Orthobunyavirus within the family Bunyaviridae. Despite reported
associations with an acute polyarthritis-like illness in Australia, TRUV and GGV have remained
genetically uncharacterised. Here we report the complete genome sequences of TRUV and
GGV which were originally isolated from mosquitoes in 1966 and 1970, respectively. Sequence
and phylogenetic analyses indicate close relationships to other characterised viruses within the
Mapputta group. These viruses exhibit the same characteristic features observed in other
viruses in the group including the absence of the NSs (non-structural) ORF and an apparent
absence of glycosylation sites on the Gn protein of GGV. We comment on the distribution of
these viruses based on the available seroprevalence data and vector feeding preferences. The
signiﬁcance of this group of viruses to public health, in terms of unidentiﬁed polyarthritic
disease, warrants further investigation.
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Phylogenetics1. Introduction
The family Bunyaviridae, incorporating ﬁve genera, is comprised of a large number of tripartite negative sense
single-stranded RNA viruses, and includes pathogens of humans, animals and plants. Bunyaviruses are arthropod borne, with
the exception of the rodent transmitted viruses of the genus Hantavirus. The human diseases caused by bunyaviruses have
been reported worldwide and include febrile illness, haemorrhagic fevers and central nervous system disorders (Soldan and
González-Scarano, 2005).
The Mapputta group of viruses is a taxonomically unclassiﬁed group in the Bunyaviridae family consisting of four serologically
related viruses isolated in Australia and Papua New Guinea; Mapputta (MAPV), Trubanaman (TRUV), Maprik (MPKV) and Gan
Gan (GGV) (Plyusnin et al., 2012). The previous suggestion that this group likely belongs to the genus Orthobunyavirus
(Newton et al., 1983) was recently conﬁrmed by the genomic sequencing of MAPV, MPKV and a new Mapputta group member,
Buffalo Creek virus (BUCV) (Gauci et al., 2015). Two viruses recently sequenced directly from mosquitoes, Murrumbidgee
(MURBV) and Salt Ash (SASHV), also belong to this group (Coffey et al., 2014; Gauci et al., 2015). GGV has been associated
with an acute epidemic polyarthritic-like illness in three patients and it is suggested that TRUV may also cause a similar illness.J. Gauci).
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associated with human disease; however, there is no genetic information publicly available for either of these viruses.
TRUV was ﬁrst isolated in February 1966 from a pool of Anopheles annulipes mosquitoes collected in October 1965 near the
Mitchell River Mission in Cape York Peninsula, Queensland (QLD) as part of an arbovirus monitoring initiative of local Aboriginal
communities (Doherty et al., 1968). Complement-ﬁxation and neutralisation testing indicated a relationship to MAPV and not any
other known Australian arbovirus (Doherty et al., 1968). TRUV has subsequently been isolated from An. annulipes in the Northern
Territory (NT) (Weir, 2002), Victoria (VIC), New South Wales (NSW) and Western Australia (WA), from Culex annulirostris in WA
and NSW (reviewed in (Mackenzie et al., 1994)) and from Anopheles meraukensis in the NT (Weir, 2002). The ﬁrst isolation of
GGV occurred in May 1970, from a pool of Aedes vigilax collected a month earlier in portable light traps set up in bushland
South West of Nelson Bay, NSW, following small recurrent outbreaks of epidemic polyarthritis in the area (Gard et al., 1973).
Complement-ﬁxation testing indicated that GGV was related to the Mapputta group but further testing distinguished it from
other members of this group and demonstrated that antigenically it is more closely related to MPKV than to MAPV or TRUV
(Marshall et al., 1980). GGV has subsequently been isolated from a pool of Culex spp. in NSW (Vale et al., 1986), and Tripteroides
atripes (Skuse) and Coquillettidia linealis (Skuse) mosquitoes in NSW (Russell et al., 1991).
Limited seroprevalence data exists for TRUV and GGV, but it appears that both are likely maintained by macropods as key host
species, with horses and to a lesser extent cattle, also involved in the transmission cycle of TRUV (Doherty et al., 1970; Johansen
et al., 2005; Vale et al., 1991). Studies in QLD, NSW and WA indicate the prevalence of neutralising antibodies for TRUV in the
studied human populations was generally low (up to 1.4%), although prevalence in Aboriginals in Cape York Peninsula have
been reported at 13% (Boughton et al., 1990; Johansen et al., 2005; Vale et al., 1991). A sero-epidemiological study, on sera
from different areas of NSW, indicated the overall prevalence of neutralising antibodies for GGV in humans was 4.7%, however,
the prevalence was more than 18% in the North West Plains region (Boughton et al., 1990). Antibodies against the related
BUCV and MAPV have also been reported in humans (Doherty et al., 1970; Weir, 2002). Here we report the ﬁrst complete genome
sequences for TRUV and GGV and discuss the potential signiﬁcance of the Mapputta group to human health.
2. Material and methods
2.1. Virus propagation and cDNA preparation
TRUV (isolate MRM3630) and GGV (isolate NB6057) were obtained from the Berrimah Veterinary Laboratories (BVL), Darwin,
NT, Australia. These viruses were included in the CSIRO Long Pocket Laboratory (LPL) virus collection that was transferred to BVL
with Steven Davis when the LPL laboratory closed. Both viruses were originally isolated through suckling mouse brain and were
subsequently propagated through cell culture. For this study, viruses were propagated through BSR cells (a subclone of the
BHK-21 cell line), harvested, total RNA extracted and converted to double stranded cDNA as previously described (Gauci et al.,
2015). All procedures were performed according to the Australian Standard AS/NZS 2243.3:10 Safety in Laboratories Part 3:
Microbiological Safety and Containment.
2.2. Full genome sequencing
The cDNA material was prepared for high-throughput sequencing using the TruSeq CHIP-seq (Illumina) protocols and standard
multiplex adaptors. A paired-end, 250-base-read protocol was used for sequencing on an Illumina MiSeq instrument, at the
University of New South Wales, Sydney, NSW. Primary assembly of raw data and generation of consensus sequences, followed
by the RACE method to obtain genome termini, were all performed as described previously (Gauci et al., 2015). The resulting
PCR products were sequenced directly using virus speciﬁc primers on the Genetic Analyser 3130xl (Applied Biosystems).
2.3. Sequence and phylogenetic analysis
Predictive ORF and protein analyses were performed as previously described (Gauci et al., 2015). To support the group
designation of the Mapputta group, MEGA5 software was used to calculate inter-group and intra-group p-distances at both the
nucleotide and amino acid level using pairwise deletion for the Mapputta group viruses and a large set of representative
orthobunyaviruses (a total of 60–80 viruses for each protein) (Tamura et al., 2011). Phylogenetic trees were constructed using
complete RNA dependent RNA polymerase (RdRp), polyprotein and nucleocapsid (N) protein sequences of bunyaviruses,
representing all ﬁve genera, accessed from GenBank and the cognate TRUV and GGV protein sequences. Sequences were aligned
using the MUSCLE 3.6 algorithm (Edgar, 2004) and Maximum likelihood (ML) and Bayesian analyses were conducted as previously
described (Gauci et al., 2015).
2.4. GenBank sequences used for phylogenetic analysis
Accession numbers for L, M and S segments accessed from GenBank are: AGUV, Aguacate virus, NC_015451, NC_015450,
NC_015452; AINOV, Aino virus, NC_018465, NC_018459, NC_018460; AKAV, Akabane virus, NC_009894, NC_009895, NC_009896;
AMBV, Anhembi virus, (L,M), JN572062, JN572063; ANAV, Anopheles A, (S), FJ660415; ANBV, Anopheles B, (S), FJ660417; ANDV,
Andes virus, NC_003468, NC_003467, NC_003466; BATV, Batai virus, (M,S), JX846596, JX846595; BeNMV, Bean necrotic mosaic
3P.J. Gauci et al. / Virology Reports 6 (2016) 1–10virus, NC_018070, NC_018072, NC_018071; BMAV, Batama virus, (S), FJ660420; BORV, Boraceia virus, (S), FJ660418; BUCV, Buffalo
Creek virus, KJ481929, KJ481928, KJ481927; BUNV, Bunyamwera virus, NC_001925, NC_001926, NC_001927; BWAV, Bwamba
virus, (S), KJ867182; CACV, Capsicum chlorosis virus, NC_008302, NC_008303, NC_008301; CCHFV, Crimean-Congo hemorrhagic
fever virus, NC_005301, NC_005300, NC_005302; CDUV, Candiru virus, NC_015374, NC_015373, NC_015375; DOBV, Dobrava virus,
NC_005235, NC_005234, NC_005233; DUGV, Dugbe virus, NC_004159, NC_004158, NC_004157; GBNV, Groundnut bud necrosis
virus, NC_003614, NC_003620, NC_003619; GERV, Germiston virus, (S), M19420; GLV, Gumbo Limbo virus, (S), KM280938; GOLV,
Gouleako virus, HQ541738, HQ541737, HQ541736; GRSV-TCSV, Groundnut ringspot and Tomato chlorotic spot virus reassortant,
NC_015469, NC_015468, NC_015467; HEBV, Herbert virus, JQ659256, JQ659257, JQ659258; HTNV, Hantaan virus, NC_005222,
NC_005219, NC_005218; HVZ10, Hantavirus 41 Z10 virus, NC_006435, NC_006437, NC_006433; INSV, Impatiens necrotic spot
virus, NC_003625, NC_003616, NC_003624; KIBV, Kibale virus, KF590577, KF590576, KF590575; LACV, La Crosse virus, NC_004108,
NC_004109, NC_004110; LEAV, Leanyer virus, HM627178, HM627176, HM627177; MADV, Madrid virus, (S), KF254781; MAGV,
Maguari (M), AY286443; MAPV, Mapputta virus, KJ481923, KJ481922, KJ481921; MCAV, Macaua virus, (L, M), JN572068,
JN572069; MPKV, Maprik virus, KJ481926, KJ481925, KJ481924; MURBV, Murrumbidgee virus, KF234253, KF234254, KF234255;
MYSV, Melon yellow spot virus, NC_008306, NC_008307, NC_008300; ORIV, Oriboca virus, (S), KF254775; OROV, Oropouche
virus, NC_005776, NC_005775, NC_005777; PUUV, Puumala virus, NC_005225, NC_005223, NC_005224; RVFV, Rift Valley Fever
virus, NC_014397, NC_014396, NC_014395; SASHV, Salt Ash virus, KF234256, KF234257, KF234258; SATV, Sathuperi virus,
NC_018461, NC_018466, NC_018462; SBV, Schmallenberg virus, JX853179, JX853180, JX853181; SEOV, Seoul virus, NC_005238,
NC_005237, NC_005236; SFSV, Sandﬂy fever Sicilian virus, NC_015412, NC_015411, NC_015413; SFTSV, Severe Feverwith Thrombocy-
topenia Syndrome virus, NC_018136, NC_018138, NC_018137; SHAV, Shamonda virus, NC_018463, NC_018467, NC_018464; SIMV,
Simbu virus, NC_018476, NC_018478, NC_018477; SNV, Sin Nombre virus, NC_005217, NC_005215, NC_005216; SORV, Sororoca
virus, (L,M), JN572071, JN572072, JN572073; TAHV, Tahyna virus, (M,S), HM036209, HM036208; TAIV, Taï virus, KF590574,
KF590573, KF590572; TCMV, Tacaiuma virus, (S), FJ660416; TETEV, Tete virus, (S), KM972721; TPMV, Thottapalayam virus,
NC_010707, NC_010708, NC_010704; TSWV, Tomato spotted wilt virus, NC_002052, NC_002050, NC_002051; TULV, Tula virus,
NC_005226, NC_005228, NC_005227; TZSV, Tomato zonate spot virus, NC_010491, NC_010490, NC_010489; UUKV, Uukuniemi
virus, NC_005214, NC_005220, NC_005221; WSMOV, Watermelon silver mottle virus, NC_003832, NC_003841, NC_003843; WYOV,
Wyeomyia virus, JN572080, JN572081, JN572082.
3. Results and discussion
3.1. Genome sequence analysis
The complete sequences of TRUV (GenBank accession no. KR013235-7) and GGV (GenBank accession no. KR013232-4) were
determined using high-throughput sequencing with genome lengths of 12,191 nt and 12,118 nt respectively. Bunyaviruses encode
the N protein on the small (S) segment, two envelope glycoproteins (Gn and Gc, translated as a polyprotein) on the medium
(M) segment and the RdRp on the large (L) segment. Orthobunyaviruses additionally encode a non-structural protein on the M
segment (NSm) and, in most cases, a non-structural protein on the S segment (NSs). The size and organisation of the TRUV
and GGV genomes are typical of bunyaviruses and similar to the genomes of the other Mapputta group viruses (Table 1).
The termini of negative sense RNA viruses typically have a high degree of complementarity allowing the formation of a
panhandle structure, an essential feature required for RNA synthesis. This feature is evident for both TRUV and GGV with a
high degree of complementarity of the terminal 22 nt of these viruses (Fig. 1). We previously reported that the 3′ terminal
sequence of MPKV does not conform to the typical 3′ terminal consensus sequence observed in other orthobunyavirusesTable 1
Genome segment sizes of TRUV and GGV in comparison with other Mapputta group viruses.
Length (nt/aa) for indicated virus
Segment Region TRUV GGV MAPV
(KJ481921-3)
MPKV
(KJ481924-6)
BUCV
(KJ481927-9)
MURBV
(KF234253-5)
SASHV
(KF234256-8)
S 3'UTR 44 50 38 50 44 33⁎ 34⁎
N ORF 714/237 711/236 711/236 711/236 714/237 714/237 714/237
5′ UTR 169 149 118 150 169 65⁎ 44⁎
Segment total 927 910 867 911 927 812⁎ 792⁎
M 3'UTR 40 50 32 46 40 31⁎ N/A
M Polyprotein ORF 4116/1371 4134/1377 4113/1370 4140/1379 4116/1371 4116/1371 4131/1377
5′ UTR 187 175 211 173 182 179⁎ N/A
Segment total 4343 4359 4356 4359 4338 4326⁎ 4131⁎
L 3'UTR 47 53 42 50 47 45⁎ 43⁎
L ORF 6729/2242 6720/2239 6726/2241 6720/2239 6729/2242 6729/2242 6637⁎/2212⁎
5′ UTR 145 76 119 73 145 146 N/A
Segment total 6921 6849 6887 6843 6921 6920⁎ 6680⁎
N/A: Not available.
The full nucleotide lengths of each segment are shown in bold.
⁎ Incomplete genome sequence.
4 P.J. Gauci et al. / Virology Reports 6 (2016) 1–10(Gauci et al., 2015). Similarly, the three genome segments of GGV and the L and M segments of TRUV, like MPKV, have a guanine
in place of an adenine at position 8 at the 3′ terminus, allowing for a second non-canonical base pairing of the aligned termini.
Interestingly, the TRUV S segment 3′ terminal sequence does conform to the typical orthobunyavirus consensus sequence. Al-
though in most cases the 11 nt terminal sequence is conserved across all three genome segments of a bunyavirus, a similar
inconsistency amongst the genome segments has been reported for other bunyaviruses (Clerx-Van Haaster et al., 1982).
3.2. S segment — N and NSs proteins
The deduced 237aa and 263aa N proteins of TRUV and GGV respectively, are of the expected size of Mapputta group viruses
(Coffey et al., 2014; Gauci et al., 2015). Of the 60 residues reported by Eifan and Elliott (2009) that are conserved in 90% of the N
proteins of the four major serogroups of the genus Orthobunyavirus, only 44 and 48 residues are conserved in TRUV and GGV
respectively. This result is similar to that found in MAPV (44), MPKV (45) and BUCV (45) previously (Gauci et al., 2015). Similarly,
the four residues with an identiﬁed role in RNP packaging, and the 10 residues important for RNA synthesis were conserved in
both viruses with the exception of one RNA synthesis residue for TRUV.
In accordance with what was previously reported for the Mapputta group viruses (Gauci et al., 2015), TRUV and GGV do not
encode a NSs protein, which is present in most other orthobunyaviruses with a few exceptions (Chowdhary et al., 2012;
Mohamed et al., 2009; Rodrigues et al., 2014). The NSs acts as an antagonist of the interferon system and is consequently involved
in the modulation of the host-cell antiviral response. Despite this, it is evident that this protein is not necessary for pathogenicity
in humans as demonstrated by GGV and another orthobunyavirus, Tacaiuma virus, which also lacks the NSs protein but is
associated with febrile illness in humans (Mohamed et al., 2009).
3.3. M segment — polyprotein
Analysis of the M polyproteins of TRUV and GGV revealed similar ﬁndings to those previously identiﬁed in other Mapputta
group viruses (Gauci et al., 2015). The M polyproteins of the Mapputta group viruses have 71 cysteine residues with the
exception of TRUV and MAPV which have 72 and 77 respectively. Alignment of the Mapputta group viruses and BUNV (which
has 70 cysteine residues) show a high conservation of cysteines with 64 residues in common. Three additional cysteine residues
are shared by all viruses of the Mapputta group but not BUNV. The high conservation of cysteine residues amongst
orthobunyaviruses has previously been noted and most likely reﬂects the similar secondary structures of the glycoproteins
(Briese et al., 2004; Grady et al., 1987; Pardigon et al., 1988). PredictProtein analysis identiﬁed six transmembrane regions in
the polyproteins of TRUV and GGV in a similar pattern previously identiﬁed in other Mapputta group viruses and consistent
with predictions of other bunyaviruses. Two regions are in the Gn (range 204–223 and 226–247), three in the NSm (range
308–327, 358–378 and 444–466) and one in the Gc (range 1330–1355). SignalP analysis predicted cleavage sites after residue
15 in the polyproteins of both TRUV and GGV, the same as that predicted in BUCV. Consistent with observations of other
orthobunyaviruses, the cleavage site between Gn and NSm is predicted to occur after a conserved arginine residue in TRUV
(R301) and GGV (R303). The SignalP predicted cleavage site between NSm and Gc in TRUV (SFA463-IA) and GGV (VNA468-EV)
is similar to that of BUCV and MPKV respectively.
NetNGlyc 1.0 analysis predicts six glycosylation sites for TRUV (1 in Gn, ﬁve in Gc) and ﬁve sites are predicted for GGV
(all in Gc). The GGV polyprotein contains a similar pattern of glycosylation sites as that found in the MPKV polyprotein, including
the highly unusual absence of a glycosylation site on the Gn protein(Gauci et al., 2015). As GGV and SASHV share high sequence
identity (Table 2), the SASHV polyprotein was analysed for the prediction of glycosylation sites and similarly found to lack glycosylation
sites on the Gn protein. The reason for the apparent absence of glycosylation sites on the Gn proteins of GGV, MPKV and SASHV is
unknown. We previously speculated that in MPKV this may have been a consequence of passage in cell culture, however, this
phenomenon in three different isolates may indicate an unusual mode of glycosylation or an evolutionary adaptation of the
Gn protein in this virus lineage.Fig. 1. Complementarity of terminal sequences of TRUV and GGV genome segments. Base pairings that allow pan-handle structure to form are joined by |.
Non-canonical base pairings are in bold.
Table 2
Nucleotide and amino acid identity comparisons for TRUV, GGV and other Mapputta Group viruses.
MAPV MPKV BUCV MURBV SASHV TRUV GGV
MAPV S – 72.0 67.8 67.8 67.9 67.4 69.9
M – 46.9 49.2 49.7 47.7 49.2 47.6
L – 62.8 59.5 59.4 61.8 59.7 62.5
MPKV S 67.9 – 70.0 70.5 87.3 70.0 90.7
M 58.0 – 48.7 48.6 61.2 48.5 61.3
L 65.9 – 61.5 61.4 86.6 61.5 87.7
BUCV S 62.8 67.5 – 98.3 68.5 97.9 70.0
M 59.3 59.2 – 98.3 49.3 98.8 49.2
L 63.7 64.7 – 99.0 59.9 99.1 60.3
MURBV S 63.9 68.6 95.8 – 67.6 98.7 69.2
M 58.6 58.6 95.9 – 49.2 99.1 49.1
L 63.7 65 95.9 – 60.0 99.3 60.4
SASHV S 68.8 81.7 67.9 67.7 – 67.6 96.6
M 58.7 64.0 57.7 57.5 – 49.2 99.7
L 64.0 76.3 64.1 64.0 – 60.0 98.8
TRUV S 63.3 68.8 96.2 97.9 67.5 – 69.2
M 59.1 59.4 96.1 98.1 57.2 – 49.1
L 63.3 64.9 96.4 98.3 63.7 – 60.4
GGV S 69.1 82.7 68.2 68.2 98.5 67.9 –
M 58.7 63.8 57.6 57.5 99.3 57.6 –
L 64.5 77.3 64.5 64.5 98.4 64.2 –
Nucleotide (bottom left) and amino acid (top right) sequence identities of complete N ORF (S segment), M polyprotein ORF (M segment) and RdRp ORF (L segment)
sequences from the Mapputta serogroup.
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The high conservation of certain regions in the RdRp of negative sense RNA viruses is reﬂective of the universal function of this
important protein. These conserved regions have previously been identiﬁed in the other Mapputta group viruses (Gauci et al.,
2015), and analyses of the RdRps of TRUV and GGV demonstrate these regions are also conserved in these viruses. For instance,
Regions I and II centred around the highly conserved dipeptides PD76 (TRUV)/PD77 (GGV) and RY650, respectively, are present, and
premotif A and motifs A-E are also evident in both TRUV and GGV.
3.5. Phylogenetic analysis
Previous phylogenetic analysis placed the Mapputta group of viruses within the genus Orthobunyavirus (Gauci et al., 2015).
Bayesian analyses of the RdRp, M polyprotein and N protein in this study demonstrate that TRUV and GGV clearly belong to
the Mapputta group of genus Orthobunyavirus (Figs. 2-4). ML analyses concur with this (data not shown). The inclusion of
TRUV and GGV into the group analysis does not alter the intra group relationships that we previously reported. Speciﬁcally,
the Mapputta group appears to split into two distinct subgroups; TRUV/MURBV/BUCV and GGV/SASHV/MPKV based on analysis
of all three proteins. In addition, while sharing a similar level of sequence identity between the two clades (S 67.4–72%; M
46.9–49.7%; L 59.4–62.8%, Table 2), the phylogenetic relationship of MAPV to the subgroups differs depending on the protein
analysed: MAPV forms a clade with GGV/SASHV/MPKV in the N tree; forms a clade with TRUV/BUCV/MURBV in the polyprotein
tree; and branches separately to all other viruses of the group in the RdRp tree. Thus it appears that the relationship of MAPV
within this group is complex and a better understanding of its position may be gained with the discovery of more MAPV-like
viruses in the future. Therefore, there is more to learn about the evolution of the group.
Evolution of viruses can be subject to selection pressure determined by factors such as environmental conditions and/or host/vector
preferences. For instance, TRUV, BUCV and MURBV have been isolated from Anopheles spp. whilst GGV, MPKV and SASHV have been
isolated from Aedes spp. (Coffey et al., 2014; Gauci et al., 2015), suggesting that vector preference may be a contributing factor in the
evolution of this group. Viral attachment to cells is mediated by interaction of the glycoproteins with vector/host receptors; this
could explain why MAPV, also isolated from Anopheles spp., is more closely related to the TRUV subgroup in the polyprotein analysis
(Fig. 3). However, TRUV and GGV have also been isolated from Culex spp. suggesting there could be opportunities for co-infection
and subsequent reassortment within the Mapputta group. Thus a historic reassortment event within the Mapputta group may also
explain the differing phylogenetic relationships of MAPV. A better understanding of the history and dynamics within this group may
be achieved as more related viruses are identiﬁed, sequenced and compared.
3.6. Viruses of the Mapputta Group
The demarcation of species of genus Orthobunyavirus is primarily deﬁned by serological criteria and, where data is available,
a difference in the aa sequence of the N proteins of more than 10% (Plyusnin et al., 2012). Pairwise sequence identities of the
N protein, polyprotein and RdRp of the seven Mapputta group viruses are shown in Table 2. This data indicates that TRUV,
MURBV and BUCV are likely strains of the same virus species, as their respective N proteins share a high aa (97.9–98.7%) and
Fig. 2. Phylogenetic relationship of the deduced RdRp protein sequence of the Mapputta Group viruses and other selected bunyaviruses were inferred by Bayesian
analysis of protein alignments. A WAG model of aa substitution with gamma + invariant site heterogeneity was used. Numbers represent Bayesian posterior
probabilities. Trees are drawn to scale measured in substitutions/site as indicated by the respective scale bar.
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cross-reactivity between TRUV and BUCV. With the identiﬁcation of TRUV, MURBV and BUCV as likely strains of the same virus,
we suggest the species name Trubanaman virus, since this was the ﬁrst virus of this species isolated. Similarly we suggest the
name Gan Gan virus for GGV and SASHV that are also likely strains of the same species due to their high N protein identity
(98.5% nt; 96.6% aa). The N proteins of GGV and MPKV share a high level (90.7%) of aa identity, however, previously published
neutralisation studies demonstrate that they appear to be distinct viruses (Gauci et al., 2015; Marshall et al., 1980).
Within the genus Orthobunyavirus, for viruses to be included in the same group, cut-offs for N protein and RdRp similarities of
59 and 60% respectively, have been proposed (Savji et al., 2011). The N proteins of the Mapputta group viruses share at least
67.4% identity (Table 2) and therefore fulﬁl these criteria to place the viruses within the same group. The RdRps of the Mapputta
group viruses generally share more than 60% identity, although the comparisons between MAPV and the Trubanaman virus iso-
lates fall marginally below this threshold (59.4–59.7% identity). In addition, it is apparent that TRUV, GGV and the other Mapputta
group viruses have some features that are characteristically different from most other orthobunyaviruses. Whilst the absence of a
NSs protein is consistent in all viruses of the Mapputta group, other differences such as the lack of a glycosylation site on the Gn
protein and non-conserved terminal sequences are not as consistent within the group. These characteristics and similarities,
together with the neutralisation studies, further support the designation of these viruses as a separate group.
To conﬁrm the placement of this group within genus Orthobunyavirus, the genome sequences of the Mapputta group viruses
were compared with published sequences of other members of genus Orthobunyavirus. To avoid any bias by over These pairwise
sequence comparisons at both the nucleotide and amino acid level, allowed the mean intragroup and intergroup p-distances to be
determined for the Mapputta group and members of Bunyamwera, California encephalitis, Simbu and Group C antigenic complexes
within the genus (Table 3). There is a clear distinction between comparisons within groups and between groups for all segments
with the exception of some crossover in the M segment for the Simbu group data. The higher values seen in the Simbu intra-group
Fig. 3. Phylogenetic relationship of the deduced M polyprotein sequence of the Mapputta Group viruses and other selected bunyaviruses were inferred by Bayesian
analysis of protein alignments. A WAG model of aa substitution with gamma + invariant site heterogeneity was used. Numbers represent Bayesian posterior
probabilities. Trees are drawn to scale measured in substitutions/site as indicated by the respective scale bar.
7P.J. Gauci et al. / Virology Reports 6 (2016) 1–10p-distances can be explained by the variability seen between the two variable Simbu group clades proposed by Ladner et al. (2014).
The mean value calculated within the Mapputta group is comparable to the mean intragroup p-distances of other orthobunyavirus
groups. Likewise, p-distance comparisons between the Mapputta group and other orthobunyavirus groups are comparable to the
intergroup p-distances calculated for the recognised groups. The intergroup and intra group calculations are therefore consistent
with the designation of Mapputta group as a distinct group.
There are now seven viruses known to belong to the Mapputta group, all have been sequenced, and cross-neutralisation data
for ﬁve members of the group suggest the viruses are related. Together with the further analysis presented here, we propose that
there is sufﬁcient data to enable formal classiﬁcation of the group into the genus Orthobunyavirus.
3.7. Signiﬁcance to human health
We previously reported that antibodies generated to MAPV, MPKV, BUCV, TRUV and GGV were able to neutralise each of
the Mapputta group viruses to varying degrees (Gauci et al., 2015). This would indicate that a positive result for any of the
Mapputta group viruses could potentially be due to an infection with other viruses of the group, and would therefore require
careful serological comparisons. Both TRUV and GGV have been associated with an epidemic polyarthritic illness similar to that
often found following infection with Ross River virus. As TRUV and GGV are not routinely tested for by the public health system it
is possible that incidences of polyarthritic disease with no known cause could be attributed to these viruses. For example, RRV-like
Fig. 4. Phylogenetic relationship of the deduced nucleocapsid protein sequence of the Mapputta Group viruses and other selected bunyaviruses were inferred by
Bayesian analysis of protein alignments. A WAG model of aa substitution with gamma + invariant site heterogeneity was used. Numbers represent Bayesian
posterior probabilities. Trees are drawn to scale measured in substitutions/site as indicated by the respective scale bar.
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outbreaks in Northern Territory (Mackenzie et al., 1994), may have been caused by TRUV, GGV or a related virus.
Previous studies that identiﬁed a higher seroprevalence of GGV in humans than TRUV were primarily focused on human
populations in coastal and central NSW, QLD and southern parts of WA (Boughton et al., 1990; Doherty et al., 1970; Johansen
et al., 2005; Vale et al., 1986). The higher seroprevalence of TRUV reported in the Cape York Peninsula indicates that TRUV
may be more prevalent in the far northern parts of Australia. Therefore further studies of more densely populated areas in the
far north, such as around Darwin, are warranted considering that isolations of TRUV and BUCV have occurred in Darwin and
BUCV was detected in a hospitalised patient there (Weir, 2002). The different seroprevalence rates may also be inﬂuenced by
the vector's feeding preferences and distribution. Ae. vigilax, the vector from which GGV has most often been isolated, readily
feeds on humans and this species is involved in the transmission of RRV and Barmah Forest virus (BFV) throughout Australia
(NSW Health, 2015a). TRUV has predominantly been isolated form An. annulipes, a species of mosquito that preferentially feeds
on animals such as cattle, and to a lesser extent on humans (NSW Health, 2015b). TRUV has, however, also been isolated from
Cx. annulirostris, which is the primary vector involved in the transmission of RRV, BFV, Murray Valley encephalitis and Kunjin
Table 3
Mean nucleotide (and amino acid) sequence difference values (%) within and between serogroups of genus Orthobunyavirus.
Comparison S segment M segment L segment
Within Mapputta 19.2 ± 1.6 (23.5 ± 1.8) 32.1 ± 0.8 (40.6 ± 0.8) 24.2 ± 0.6 (29.2 ± 0.6)
Within Bunyamwera 14.4 ± 1.1 (16.8 ± 1.3) 30.3 ± 0.7 (38.5 ± 0.8) 21.8 ± 0.6 (24.5 ± 0.6)
Within California 12.5 ± 1.1 (14.9 ± 1.5) 20.7 ± 0.7 (25.2 ± 0.7) 13.4 ± 0.5 (12.2 ± 0.5)
Within Simbu 22.3 ± 1.4 (26.7 ± 1.9) 43.2 ± 0.6 (55.1 ± 0.8) 28.3 ± 0.5 (33.0 ± 0.6)
Within Group C 15.8 ± 1.4 (18.4 ± 1.6) 22.2 ± 0.8 (26.6 ± 0.8) 16.0 ± 0.5 (17.4 ± 0.6)
Between Mapputta and Bunyamwera 46.6 ± 2.7 (63.1 ± 2.8) 51.6 ± 1.0 (66.1 ± 1.0) 41.3 ± 0.8 (51.0 ± 0.9)
Between Mapputta and California 43.9 ± 2.7 (56.8 ± 2.6) 51.8 ± 1.0 (66.5 ± 1.0) 39.3 ± 0.7 (49.3 ± 0.9)
Between Mapputta and Simbu 47.6 ± 2.5 (62.6 ± 2.7) 54.0 ± 0.8 (69.4 ± 0.9) 42.8 ± 0.7 (53.0 ± 0.9)
Between Mapputta and Group C 51.9 ± 2.5 (62.9 ± 2.6) 52.0 ± 1.0 (67.4 ± 1.1) 41.4 ± 0.8 (51.9 ± 1.0)
Between Bunyamwera and California 42.3 ± 2.9 (55.6 ± 2.9) 43.5 ± 0.9 (57.1 ± 1.0) 37.0 ± 0.8 (45.0 ± 0.9)
Between Bunyamwera and Simbu 46.0 ± 2.4 (59.4 ± 2.8) 51.2 ± 0.7 (66.4 ± 0.9) 41.0 ± 0.7 (50.6 ± 0.8)
Between Bunyamwera and Group C 45.9 ± 2.6 (59.4 ± 2.8) 50.3 ± 1.0 (64.7 ± 1.1) 39.5 ± 0.7 (49.1 ± 0.9)
Between California and Simbu 43.5 ± 2.4 (57.1 ± 2.8) 51.6 ± 0.8 (67.5 ± 0.9) 39.8 ± 0.8 (48.8 ± 0.8)
Between California and Group C 43.3 ± 2.7 (56.5 ± 2.8) 50.9 ± 1.1 (66.0 ± 1.1) 38.8 ± 0.9 (48.3 ± 1.0)
Between Group C and Simbu 44.5 ± 2.3 (60.9 ± 2.8) 52.1 ± 0.8 (68.0 ± 1.0) 38.8 ± 0.8 (47.5 ± 0.9)
9P.J. Gauci et al. / Virology Reports 6 (2016) 1–10viruses (NSW Health, 2015c). It would be an interesting future study to investigate the potential for co-infection of the Mapputta
group viruses with known viruses, such as RRV and BFV, and the contribution such an event may have on the development and
severity of disease commonly attributed to the known viruses. The recent development and assessment of a RRV vaccine
(Wressnigg et al., 2015) further highlights the importance polyarthritic disease plays in Australia.
In conclusion, the known propensity of these vectors to transmit viruses of high public health concern in Australia, and the
links of GGV and TRUV to polyarthritic disease, strongly suggest that a comprehensive survey of human sera should be performed
to provide a clearer understanding of the role of this group of viruses in human disease.
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